PRGON Stock Chart & Stats
$176.70
-$400.24(-69.37%)
At close: 4:00 PM EDT
$176.70
-$400.24(-69.37%)
Day’s Range― - ―
52-Week Range$176.00 - $576.94
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$24.86B
Enterprise Value$4.77K
Total Cash (Recent Filing)$357.20M
Total Debt (Recent Filing)$3.81B
Price to Earnings (P/E)―
Beta0.04
Next Earnings
Aug 05, 2026EPS Estimate
5.93Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-13.11
Shares Outstanding138,367,770
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.66
Price to Sales (P/S)0.45
P/FCF Ratio13.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$297.23Price Target Upside68.21% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Perrigo Company News
PRGON FAQ
What was Perrigo Company’s price range in the past 12 months?
Perrigo Company lowest stock price was $176.00 and its highest was $576.94 in the past 12 months.
What is Perrigo Company’s market cap?
Perrigo Company’s market cap is $24.86B.
When is Perrigo Company’s upcoming earnings report date?
Perrigo Company’s upcoming earnings report date is Aug 05, 2026 which is in 5 days.
How were Perrigo Company’s earnings last quarter?
Perrigo Company released its earnings results on May 06, 2026. The company reported $7.499 earnings per share for the quarter, beating the consensus estimate of $5.354 by $2.145.
Is Perrigo Company overvalued?
According to Wall Street analysts Perrigo Company’s price is currently Undervalued.
Does Perrigo Company pay dividends?
Perrigo Company does not currently pay dividends.
What is Perrigo Company’s EPS estimate?
Perrigo Company’s EPS estimate is 5.93.
How many shares outstanding does Perrigo Company have?
Perrigo Company has 138,367,770 shares outstanding.
What happened to Perrigo Company’s price movement after its last earnings report?
Perrigo Company reported an EPS of $7.499 in its last earnings report, beating expectations of $5.354. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Perrigo Company?
Currently, no hedge funds are holding shares in MX:PRGON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Perrigo Company Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$297.23 (68.21% Upside)
$297.23 (68.21% Upside)
Blogger Sentiment
Bullish
MX:PRGON Sentiment 70%
Sector Average ―
Sector Average ―
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.03%
12-Months-Change
Fundamentals
Return on Equity
34.41%
Trailing 12-Months
Asset Growth
-18.20%
Trailing 12-Months
Company Description
Perrigo Company
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
PRGON Company Deck
PRGON Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed picture: clear operational and commercial progress (market share gains, meaningful cost-savings program, completion of a divestiture and reaffirmed guidance) contrasted with material near-term revenue and margin headwinds (notably CORE net sales down ~8.3% YoY, gross/operating margin compression, a $331M goodwill impairment and cash flow pressure). Management emphasized these headwinds are largely transitory and the majority of growth and margin recovery is expected in the second half of 2026, supported by innovation, demand generation and operational improvements.View all MX:PRGON earnings summariesPRGON Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$297.23
▲(68.21% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month









